Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

immunity · Mechanism Report

Do persistent IgG antibodies to Borrelia, Ehrlichia, or Rickettsia indicate active infection?

Persistent IgG to Borrelia, Ehrlichia, or Rickettsia usually reflects prior exposure and immune memory, not active infection by itself.

UnsupportedSeptember 23, 20266 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

IgG antibodies to Borrelia, Ehrlichia, and Rickettsia can persist after prior exposure, so isolated IgG reactivity reflects immune memory and does not by itself establish active infection.

laying out figure…
1 of 4 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says isolated IgG reactivity can remain after past infection with these tick-borne pathogens. The mechanism framing emphasizes durable humoral immune memory and shows that a single IgG result cannot time exposure or confirm ongoing disease on its own. It also points to paired serology or direct pathogen detection as more informative for active infection.

Verified conclusion

In an 83-year-old man, positive serology for tick-borne pathogens should be interpreted in the context of symptoms, timing, exposure history, and confirmatory testing rather than treated as evidence of ongoing infection alone.

Persistence and clinical interpretation

  • Borrelia burgdorferi IgG can remain detectable for 10–20 years or longer after treated Lyme borreliosis, including in people without evidence of viable organisms.
  • Ehrlichia chaffeensis IgG may persist for months to years, often declining substantially during the first year.
  • For Rickettsia typhi, longitudinal IFA data estimated a median IgG half-life of 177 days, with marked individual variation; CDC notes antibodies may remain elevated for months to years.
  • Thus, an isolated IgG-positive result primarily documents prior antigen exposure and durable humoral immune memory. It does not determine when exposure occurred or, without other evidence, establish that infection is active.

Diagnostic implications

  • A single rickettsial IgG titer—even a reciprocal titer ≥1:64—is supportive rather than confirmatory. In a clinically compatible illness, paired acute and convalescent specimens obtained about 2–4 weeks apart showing a ≥4-fold IgG rise provide stronger confirmation of recent infection.
  • The same principle applies to ehrlichiosis: a single acute IgG result is presumptive, whereas seroconversion or a fourfold rise on paired testing is more informative.
  • Direct pathogen detection can address active infection more directly: detection of R. typhi DNA by PCR supports active disease, although a negative PCR does not exclude it, particularly depending on specimen timing and doxycycline exposure. Rickettsial serology may also cross-react across antigen groups.

Bottom line

  • Persistent IgG to Borrelia, Ehrlichia, or Rickettsia is compatible with remote exposure and immune memory; management should rest on compatible current illness plus temporal serology and/or appropriate direct detection, not isolated IgG reactivity.

References

  1. Suggested Reporting Language, Interpretation and Guidance for Lyme Disease Serologic Testing Results — cdc.gov ↗
  2. Clinical Practice Guidelines by the Infectious Diseases ... — gc.nh.gov ↗
  3. Diagnosis and Management of Tickborne Rickettsial Diseases ... — cdc.gov ↗
  4. Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and Anaplasmosis — United States — cdc.gov ↗
  5. EHRC - Overview: Ehrlichia chaffeensis (HME) Antibody, IgG, Serum — mayocliniclabs.com ↗
  6. Clinical Testing and Diagnosis for Ehrlichiosis — cdc.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Unsupported4 sourcesDoes a positive Anaplasma IgM alone diagnose active anaplasmosis?→Plausible13 sourcesCan gliotoxin and mycophenolic acid alter immune processes without proving neural autoimmunity?→